Cargando…

The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the EGFR-Mutated Lung Cancer

Despite the recent development of precision medicine and targeted therapies, lung cancer remains the top cause of cancer-related mortality worldwide. The patients diagnosed with metastatic disease have a five-year survival rate lower than 6%. In metastatic disease, EGFR is the most common driver of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fregni, Matilde, Ciribilli, Yari, Zawacka-Pankau, Joanna E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267050/ https://www.ncbi.nlm.nih.gov/pubmed/35806218 http://dx.doi.org/10.3390/ijms23137213

Ejemplares similares

The Role of p53 Family in Cancer
por: Zawacka-Pankau, Joanna E.
Publicado: (2022)

The Undervalued Avenue to Reinstate Tumor Suppressor Functionality of the p53 Protein Family for Improved Cancer Therapy-Drug Repurposing
por: Zawacka-Pankau, Joanna E.
Publicado: (2020)

The p53/MDM2/MDMX-targeted therapies—a clinical synopsis
por: Jiang, Liren, et al.
Publicado: (2020)

Protoporphyrin IX is a dual inhibitor of p53/MDM2 and p53/MDM4 interactions and induces apoptosis in B-cell chronic lymphocytic leukemia cells
por: Jiang, Liren, et al.
Publicado: (2019)

P53 Family Members Modulate the Expression of PRODH, but Not PRODH2, via Intronic p53 Response Elements
por: Raimondi, Ivan, et al.
Publicado: (2013)

APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
por: Zhang, Qiang, et al.
Publicado: (2018)

Correction: APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
por: Zhang, Qiang, et al.
Publicado: (2019)

Activation of TAp73 and inhibition of TrxR by Verteporfin for improved cancer therapy in TP53 mutant pancreatic tumors
por: Acedo, Pilar, et al.
Publicado: (2019)

The Changes in the p53 Protein across the Animal Kingdom Point to Its Involvement in Longevity
por: Bartas, Martin, et al.
Publicado: (2021)

The use of ion mobility mass spectrometry to probe modulation of the structure of p53 and of MDM2 by small molecule inhibitors
por: Dickinson, Eleanor R., et al.
Publicado: (2015)

Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in TP53-deficient cancer cells
por: Sznarkowska, Alicja, et al.
Publicado: (2018)

Correction to: Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in TP53-deficient cancer cells
por: Sznarkowska, Alicja, et al.
Publicado: (2019)

Whole-genome cartography of p53 response elements ranked on transactivation potential
por: Tebaldi, Toma, et al.
Publicado: (2015)

Altered Expression of Shorter p53 Family Isoforms Can Impact Melanoma Aggressiveness
por: Tadijan, Ana, et al.
Publicado: (2021)

Evolution of p53 Transactivation Specificity through the Lens of a Yeast-Based Functional Assay
por: Lion, Mattia, et al.
Publicado: (2015)

Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule
por: Grinkevich, Vera V., et al.
Publicado: (2022)

Expression profiles of p53/p73, NME and GLI families in metastatic melanoma tissue and cell lines
por: Ozretić, Petar, et al.
Publicado: (2019)

p53 Transactivation and the Impact of Mutations, Cofactors and Small Molecules Using a Simplified Yeast-Based Screening System
por: Andreotti, Virginia, et al.
Publicado: (2011)

ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis
por: Shi, Y, et al.
Publicado: (2014)

Deferasirox-Dependent Iron Chelation Enhances Mitochondrial Dysfunction and Restores p53 Signaling by Stabilization of p53 Family Members in Leukemic Cells
por: Calabrese, Chiara, et al.
Publicado: (2020)

Metabolic Regulation by p53 Family Members
por: Berkers, Celia R., et al.
Publicado: (2013)

Oncogenomics of c-Myc transgenic mice reveal novel regulators of extracellular signaling, angiogenesis and invasion with clinical significance for human lung adenocarcinoma
por: Ciribilli, Yari, et al.
Publicado: (2017)

Identification of new p53 target microRNAs by bioinformatics and functional analysis
por: Bisio, Alessandra, et al.
Publicado: (2013)

Correction: Oncogenomics of c-Myc transgenic mice reveal novel regulators of extracellular signaling, angiogenesis and invasion with clinical significance for human lung adenocarcinoma
por: Ciribilli, Yari, et al.
Publicado: (2018)

Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code
por: Ciribilli, Yari, et al.
Publicado: (2013)

Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53‐altered tumors
por: Gunaratne, Preethi H., et al.
Publicado: (2019)

Cooperative interactions between p53 and NFκB enhance cell plasticity
por: Bisio, Alessandra, et al.
Publicado: (2014)

The Coordinated P53 and Estrogen Receptor Cis-Regulation at an FLT1 Promoter SNP Is Specific to Genotoxic Stress and Estrogenic Compound
por: Ciribilli, Yari, et al.
Publicado: (2010)

Emerging Roles of p53 Family Members in Glucose Metabolism
por: Itahana, Yoko, et al.
Publicado: (2018)

c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma
por: Ciribilli, Yari, et al.
Publicado: (2016)

The p53 family member p73 in the regulation of cell stress response
por: Rozenberg, Julian M., et al.
Publicado: (2021)

The expression of the EGFR family members in breast carcinomas
por: Suo, Z, et al.
Publicado: (2000)

MIF Family Members Cooperatively Inhibit p53 Expression and Activity
por: Brock, Stephanie E., et al.
Publicado: (2014)

Oncogenic Intra-p53 Family Member Interactions in Human Cancers
por: Ferraiuolo, Maria, et al.
Publicado: (2016)

TP53 Co-Mutations in Advanced EGFR-Mutated Non–Small Cell Lung Cancer: Prognosis and Therapeutic Strategy for Cancer Therapy
por: Liu, Surui, et al.
Publicado: (2022)

Editorial: Transcriptional Regulation as a Key Player in Cancer Cells Drug Resistance
por: Martinez-Balibrea, Eva, et al.
Publicado: (2021)

Decoding c-Myc networks of cell cycle and apoptosis regulated genes in a transgenic mouse model of papillary lung adenocarcinomas
por: Ciribilli, Yari, et al.
Publicado: (2015)

Differences in the transactivation domains of p53 family members: a computational study
por: Mavinahalli, Jagadeesh N, et al.
Publicado: (2010)

Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations
por: Ruiz-Cordero, Roberto, et al.
Publicado: (2020)

The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1
por: Voena, C, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tavt425bp1qvnhel7oltn3i5bu